August 17, 2016

A Second Modular Biopharma Facility Opens: KUBio in Hangzhou

To bring advanced biosimilar products to the Chinese market quickly, Pfizer’s Global Biotechnology Center will make use of Cytiva’s KUBio advanced modular manufacturing solution. KUBio modules are pre-fabricated with Cytiva’s Flexfactory processing technology that significantly reduces construction and installation time. The center will also include filling and packaging lines providing end-to-end manufacturing capability in a single facility.

Read more here

Tags: Flex Factory, KUBio, china, monoclonal antibodies, Mabs, Biosimilars